Biochemical and histopathological alterations in TAR DNA-binding protein-43 after acute ischemic stroke in rats

Journal of Neurochemistry

Volumn 116, Issue 6, 2011, Pages 957-965

  Kanazawa, Masato ^a   Kakita, Akiyoshi ^a   Igarashi, Hironaka ^a   Takahashi, Tetsuya ^a   Kawamura, Kunio ^a   Takahashi, Hitoshi ^a   Nakada, Tsutomu ^a   Nishizawa, Masatoyo ^a   Shimohata, Takayoshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

caspase 3; ischemia; proteolysis; rat; TAR DNA binding protein 43

Indexed keywords

TAR DNA BINDING PROTEIN; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW; BRAIN ISCHEMIA; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; SOLUBILITY; UBIQUITINATION;

ANIMALS; BRAIN; CELL COUNT; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; IN SITU NICK-END LABELING; INJECTIONS, INTRAVENTRICULAR; ISCHEMIA; MALE; MOLECULAR WEIGHT; NEURONS; OLIGOPEPTIDES; PHOSPHORYLATION; PROTEIN TRANSPORT; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; STROKE; TIME FACTORS; UBIQUITIN;

RATTUS;

EID: 79952375490     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06860.x     Document Type: Article

References (28)

1. Arai T., Hasegawa M., Akiyama H., et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic (Pubitemid 44708852)
2. Ayala Y. M., Misteli T., and, Baralle F. E., (2008) TDP-43 regulates retinoblastoma protein phosphorylation through the repression of cyclin-dependent kinase 6 expression. Proc. Natl Acad. Sci. USA 105, 3785-3789. (Pubitemid 351723476)
3. Buratti E., and, Baralle F.,. (2009) The molecular links between TDP-43 dysfunction and neurodegeneration, in Advances in Genetics (, Friedmann T., Dunlap J. C., and, Goodwin S. F., eds), Vol. 66, pp. 1-34. Elsevier Inc., Amsterdam.
4. Forman M. S., Trojanowski J. Q., and, Lee V. M. Y., (2007) TDP-43: a novel neurodegenerative proteinopathy. Curr. Opin. Neurobiol. 17, 548-555.
5. Giordana M. T., Piccinini M., Grifoni S., de Marco G., Vercellino M., Magistrello M., Pellerino A., Buccinnà B., Lupino E., and, Rinaudo M. T., (2009) TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis. Brain Pathol. 20, 351-360.
6. Hasegawa M., Arai T., Nonaka T., et al. (2008) Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70.
7. Kakita A., Zerlin M., Takahashi H., and, Goldman J. E., (2003) Some glial progenitors in the neonatal subventricular zone migrate through the corpus callosum to the contralateral cerebral hemisphere. J. Comp. Neurol. 458, 381-388. (Pubitemid 36337054)
8. Katchanov J., Harms C., Gertz K., et al. (2001) Mild cerebral ischemia induces loss of cyclin-dependent kinase inhibitors and activation of cell cycle machinery before delayed neuronal cell death. J. Neurosci. 21, 5045-5053. (Pubitemid 32622930)
9. Katsura K., Takahashi K., Asoh S., et al. (2008) Combination therapy with transductive anti-death FNK protein and FK506 ameliorates brain damage with focal transient ischemia in rat. J. Neurochem. 106, 258-270. (Pubitemid 351840209)
10. Lee E. B., Lee V. M., Trojanowski J. Q., and, Neumann M., (2008) TDP-43 immunoreactivity in anoxic, ischemic and neoplastic lesions of the central nervous system. Acta Neuropathol. 115, 305-311.
11. Mackenzie I. R., Neumann M., Bigio E. H., et al. (2010) Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1-4.
12. Memezawa H., Smith M. L., and, Siesjo B. K., (1992) Penumbral tissues salvaged by reperfusion following middle cerebral artery occlusion in rats. Stroke 23, 552-559.
13. Moisse K., Volkening K., Leystra-Lantz C., Welch I., Hill T., and, Strong M. J., (2009a) Divergent patterns of cytosolic TDP-43 and neuronal progranulin expression following axotomy: implications for TDP-43 in the physiological response to neuronal injury. Brain Res. 1249, 202-211.
14. Moisse K., Mepham J., Volkening K., Welch I., Hill T., and, Strong M. J., (2009b) Cytosolic TDP-43 expression following axotomy is associated with caspase 3 activation in NFL-/- mice: support for a role for TDP-43 in the physiological response to neuronal injury. Brain Res. 1296, 176-186.
15. Neumann M., Sampathu D. M., Kwong L. K., et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133. (Pubitemid 44547757)
16. Nonaka T., Arai T., Buratti E., Baralle F. E., Akiyama H., and, Hasegawa M., (2009a) Phosphorylated and ubiquitinated TDP-43 pathological inclusions in ALS and FTLD-U are recapitulated in SH-SY5Y cells. FEBS Lett. 583, 394-400.
17. Nonaka T., Kametani F., Arai T., Akiyama H., and, Hasegawa M., (2009b) Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353-3364.
18. Pesiridis G. S., Lee V. M., and, Trojanowski J. Q., (2009) Mutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, R156-R162.
19. Schotte P., Declercq W., Van Huffel S., Vandenabeele P., and, Beyaert R., (1999) Non-specific effects of methyl ketone peptide inhibitors of caspases. FEBS Lett. 442, 117-121. (Pubitemid 29065390)
20. Shimohata T., Zhao H., Sung J. H., Sun G., Mochly-Rosen D., and, Steinberg G. K., (2007) Suppression of δPKC activation after focal cerebral ischemia contributes to the protective effect of hypothermia. J. Cereb. Blood Flow Metab. 27, 1463-1475. (Pubitemid 47106606)
21. Sreedharan J., Blair I. P., Tripathi V. B., et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-16672.
22. Strong M. J., Volkening K., Hammond R., Yang W., Strong W., Leystra-Lantz C., and, Shoesmith C., (2007) TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol. Cell. Neurosci. 35, 320-327. (Pubitemid 46843567)
23. Wang H. Y., Wang I. F., Bose J., and, Shen C. K., (2004) Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130-139. (Pubitemid 37518267)
24. Wang I. F., Wu L. S., Chang H. Y., and, Shen C. K., (2008) TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor. J. Neurochem. 105, 797-806.
25. Winton M. J., Igaz L. M., Wong M. M., Kwong L. K., Trojanowski J. Q., and, Lee V. M., (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redisturbance, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309.
26. Yokoseki A., Shiga A., Tan C.-F., et al. (2008) TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63, 538-542. (Pubitemid 351614721)
27. Zhang Y. J., Xu Y. F., Dickey C. A., Buratti E., Baralle F., Bailey R., Pickering-Brown S., Dickson D. W., and, Petrucelli L., (2007) Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43. J. Neurosci. 27, 10530-10534. (Pubitemid 47501990)
28. Zhang Y. J., Xu Y. F., Cook C., et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc. Natl Acad. Sci. USA 106, 7607-7612.